Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00797706
Recruitment Status : Unknown
Verified February 2010 by Kringle Pharma Europe AB.
Recruitment status was:  Active, not recruiting
First Posted : November 25, 2008
Last Update Posted : February 5, 2010
Kringle Pharma, Inc.
Information provided by:
Kringle Pharma Europe AB

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2010
  Estimated Study Completion Date : March 2010